Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1115.57
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Patrick John Henry Campbell has worked on the following 201 EPO patent applications which have been published in the last five years:

EP11720278

HIGH CONCENTRATION ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, A61K 47/12, C07K 16/22
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP11731455

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61K 48/00, A61K 49/04, C07C 217/08, C07C 217/46, C07C 229/12, C07C 229/30, C07C 237/06, C07C 271/20, C07C 327/06, C07D 233/60, C07D 249/04, C12N 15/11, C12N 15/88
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11745910

ANTIBODIES THAT BIND MYOSTATIN, COMPOSITIONS AND METHODS

IPC classification:
A61P 19/08, A61P 21/00, C07K 16/22
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12734409

INFECTIOUS HEPATITIS E VIRUS GENOTYPE 3 RECOMBINANTS

IPC classification:
A61K 39/29
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11818848

METHODS OF TREATING MILD COGNITIVE IMPAIRMENT (MCI) AND RELATED DISORDERS

IPC classification:
A01N 43/42, A61K 31/44, A61P 25/28
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12751893

MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS

IPC classification:
C07K 14/47, C07K 14/485, C07K 14/605, C07K 14/76, C07K 16/00, C07K 16/18, C07K 16/30, C07K 19/00
Applicant:
Zymeworks Inc
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12752965

DIRECT REPROGRAMMING OF HUMAN FIBROBLASTS TO FUNCTIONAL NEURONS UNDER DEFINED CONDITIONS

IPC classification:
C12N 5/07
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11753297

HIGHLY PRODUCTIVE ISOPROPYL ALCOHOL-PRODUCING BACTERIUM

IPC classification:
C12N 1/21, C12N 15/09, C12P 7/04
Applicant:
Mitsui Chemicals Inc
Agent:
Multiple attorneys, J A Kemp
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11816495

ISOPROPYL ALCOHOL-PRODUCING BACTERIUM HAVING IMPROVED PRODUCTIVITY BY GNTR DESTRUCTION

IPC classification:
C12N 1/21, C12N 15/09, C12P 7/04
Applicant:
Mitsui Chemicals Inc
Agent:
Multiple attorneys, J A Kemp
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12710424

BIOMARKER FOR CORONARY ARTERY DISEASE

IPC classification:
G01N 33/564, G01N 33/68, G01N 33/92
Applicant:
The Board of Regents of the University of Nebraska
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12760812

PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS

IPC classification:
A01N 43/54, A61K 31/497, A61K 31/505, C07D 401/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12711543

ANTI - SCLEROSTIN ANTIBODY CRYSTALS AND FORMULATIONS THEREOF

IPC classification:
A61K 39/395, C07K 16/22
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12716858

METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Christian Rupp, Mitscherlich PartmbB
Status:
GRANT OF PATENT INTENDED
EP12723771

PRODRUGS OF INHIBITORS OF PLASMA KALLIKREIN

IPC classification:
A61K 31/402, A61K 31/415, A61P 9/10, C07D 207/34, C07D 231/14
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11799007

COMBINATION THERAPY WITH CRYOSURGERY AND LOW DOSAGE STRENGTH IMIQUIMOD TO TREAT ACTINIC KERATOSIS

IPC classification:
A01N 43/42, A61B 18/02, A61K 9/06, A61K 9/107, A61K 31/437, A61K 33/00, A61K 47/10, A61K 47/26
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13156603

Hyperphotosynthetic organisms

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/53
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11769758

BREAST CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS

IPC classification:
C12Q 1/68, G01N 33/48
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13190308

Identification and enrichment of cell subpopulations

IPC classification:
A61K 39/395, C07K 16/22, C07K 16/28, C07K 16/30, C07K 16/40, C12N 5/09
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Martin Douglas Hyden, Finnegan Europe LLP
Agent:
Multiple attorneys, Finnegan LLP
Status:
GRANT OF PATENT INTENDED
EP12807429

MULTIGENE PROGNOSTIC ASSAY FOR LUNG CANCER

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12717002

METHOD FOR TREATING OSTEOPOROSIS

IPC classification:
A61K 39/395
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12819719

MICROORGANISM HAVING CARBON DIOXIDE FIXATION PATHWAY INTRODUCED THEREINTO

IPC classification:
C12N 1/21, C12N 15/09, C12P 7/04, C12P 7/28, C12P 19/32
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP12746235

METHOD FOR TREATING BONE GAP DEFECTS

IPC classification:
A61K 39/395, A61P 19/00, C07K 16/22
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12821759

METHOD FOR PRODUCING ISOPROPYL ALCOHOL BY CONTINUOUS CULTURE

IPC classification:
C12N 15/09, C12P 7/04
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12759331

PROFILING OF SIGNAL PATHWAY PROTEINS TO DETERMINE THERAPEUTIC EFFICACY

IPC classification:
G01N 33/50, G01N 33/542
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Christian Rupp, Mitscherlich PartmbB
Agent:
Sri Krishnan, Nestec S.A.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12746691

SORAFENIB DERIVATIVES AS sEH INHIBITORS

IPC classification:
A61K 31/44, C07C 275/30, C07C 275/34, C07D 213/64, C07D 213/79, C07D 213/81
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP12837234

METHOD FOR PRODUCING POLYPEPTIDE FRAGMENT WITH HIGH EFFICIENCY, WHICH IS SUITABLE FOR NCL METHOD

IPC classification:
C07C 279/22, C07K 1/06, C07K 1/12, C12N 15/00, C12P 21/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12846333

COLORECTAL CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12842733

BACTERIAL PRODUCTION OF METHYL KETONES

IPC classification:
C08G 63/06, C12P 7/62
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12843242

ANTIBODY FORMULATIONS AND METHODS

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12845801

STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION IN PROGRESS
EP12851734

SELECTIVE KINASE INHIBITORS

IPC classification:
A61K 31/506
Applicant:
Portola Pharmaceuticals, Inc.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12852197

PYRAZINE KINASE INHIBITORS

IPC classification:
A61K 31/4965
Applicant:
Portola Pharmaceuticals, Inc.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12853122

GLUCOMANNAN SCAFFOLDING FOR THREE-DIMENSIONAL TISSUE CULTURE AND ENGINEERING

IPC classification:
C12N 5/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12852729

IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY

IPC classification:
C07K 1/22, C07K 7/08, C07K 16/00, C07K 17/00, C07K 19/00, C12N 15/09, G01N 33/53
Applicant:
Otsuka Chemical Co., Ltd.
Applicant:
Kagoshima University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13197830

Fuel composition comprising a mixture of n-alkanes

IPC classification:
C07C 11/02, C10L 1/02, C12N 1/21, C12N 9/02, C12N 9/04, C12N 9/88, C12P 5/02, C12P 7/04
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12855900

METHOD OF THERAPY SELECTION FOR PATIENTS WITH CANCER

IPC classification:
A61K 48/00, A61P 35/00, G01N 33/15
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Christian Rupp, Mitscherlich PartmbB
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP12856145

METHOD FOR DETECTING PROTEIN-PROTEIN INTERACTION

IPC classification:
C12N 15/09, C12Q 1/02, G01N 21/64, G01N 33/15, G01N 33/50, G01N 33/53, G01N 33/542, G01N 33/566
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP14175853

Stem cell cultures

IPC classification:
C07D 513/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP12857505

PREDICTING RESPONSIVENESS TO ANTIBODY MAINTENANCE THERAPY

IPC classification:
C07K 16/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12815856

CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

IPC classification:
A61K 31/713, C12N 15/11, C12N 15/113
Applicant:
Tokyo Medical and Dental University
Applicant:
Osaka University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12858631

MODIFICATION OF HELPER T CELL-INDUCING POLYPEPTIDE

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/245, A61K 39/39, A61P 1/16, A61P 1/18, A61P 3/10, A61P 19/02, A61P 25/00, A61P 35/00, A61P 35/02, A61P 37/00, A61P 37/08, C07K 7/08, C07K 14/77, C07K 14/82, C12N 15/09
Applicant:
Kochi University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13195355

Engineered CO2 fixing microorganisms producing carbon-based products of interest

IPC classification:
C12M 1/00, C12M 3/00
Agent:
Multiple attorneys, J A Kemp
Agent:
Hazel Ford, Finnegan Europe LLP
Status:
EXAMINATION IN PROGRESS
EP12860828

TELODENDRIMERS WITH ENHANCED DRUG DELIVERY

IPC classification:
A61K 51/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12860175

REACTIVE OXYGEN SPECIES-RESISTANT MICROORGANISMS

IPC classification:
C07H 21/04, C12N 1/20, C12N 1/21, C12N 15/31, C12N 15/52, C12P 7/06
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12862096

SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

IPC classification:
A61K 31/44
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12862525

SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

IPC classification:
A01N 35/00, A61K 31/11
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14171183

Hydrogel comprising cells for local release of growth factors to mediate motor recovery after stroke

IPC classification:
A61K 38/18, A61L 27/38, A61L 27/52, A61P 25/00
Applicant:
BioTime Inc
Applicant:
The Regents of the University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14173519

Selectively targeted antimicrobial peptides and the use thereof

IPC classification:
A01N 37/46, A61K 38/00, C07K 7/00, C07K 7/06, C07K 7/08, C07K 14/00, C07K 14/315
Applicant:
The Regents of the University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12864101

SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING AMINO ACID BACKBONE

IPC classification:
A61K 48/00, C07C 225/06, C12N 15/113
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14169140

Silencing of CSN5 gene expression using interfering RNA

IPC classification:
C12N 15/11
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12809999

VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF

IPC classification:
A61K 31/55, A61K 38/17, A61K 45/06, A61P 35/00, C07K 14/71
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12863477

AMADORIASE HAVING IMPROVED THERMAL STABILITY, GENE AND RECOMBINANT DNA OF SAME, AND METHOD FOR PRODUCING AMADORIASE HAVING IMPROVED THERMAL STABILITY

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 9/06, C12N 15/09, C12Q 1/26
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12807138

MEGAKARYOCYTE PROGENITOR CELLS FOR PRODUCTION OF PLATELETS

IPC classification:
A61K 35/14, C12N 5/00, C12N 5/078
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12842939

FLT3 MUTATIONS ASSOCIATED WITH DRUG RESISTANCE IN AML PATIENTS HAVING ACTIVATING MUTATIONS IN FLT3

IPC classification:
A61K 38/16, A61K 38/17, A61K 48/00, A61P 35/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13742871

SYSTEM FOR DELIVERING MEDICATION

IPC classification:
A61M 5/14, A61M 5/178, G01D 13/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13742902

THERAPEUTIC CUSHION SYSTEMS AND METHODS

IPC classification:
A47C 20/00, A61G 7/07
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13746448

BENZOTHIOPHENE COMPOUND, ALTERNATIVE AUTOPHAGY-INDUCING AGENT AND ANTICANCER DRUG INCLUDING BENZOTHIOPHENE COMPOUND AS ACTIVE INGREDIENT, AND METHOD FOR SCREENING FOR COMPOUNDS HAVING ANTICANCER ACTIVITY

IPC classification:
A61K 31/382, A61P 35/00, A61P 35/02, A61P 43/00, C07D 333/68, G01N 33/15, G01N 33/50
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP13747275

SUBSTRATES, PEPTIDE ARRAYS, AND METHODS

IPC classification:
C07K 1/04, C07K 1/10, C12Q 1/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13748609

ENZYMES AND METHODS FOR CLEAVING N-GLYCANS FROM GLYCOPROTEINS

IPC classification:
A23L 1/29, A61K 38/08, C07K 7/06, C12N 15/52
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13744084

HUMAN MONOCLONAL ANTIBODIES BROADLY PROTECTIVE AGAINST INFLUENZA B VIRUS AND METHODS OF USING THE SAME

IPC classification:
A61K 39/395, A61P 31/16, C07K 16/10, C12N 15/02, C12P 21/08, G01N 33/569
Applicant:
The Research Foundation for Microbial Diseases of Osaka University
Applicant:
Osaka University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13748805

GREEN SULFUR BACTERIA VARIANT AND BACTERIOCHLOROPHYLL

IPC classification:
C12N 1/20, C12N 1/21, C12N 15/09, C12P 9/00
Applicant:
Kurume University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13707529

ANTI SEZ6 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13191438

Colour pigment powder, pigment dispersion and method of manufacture

IPC classification:
A61K 8/19, A61K 8/25, A61K 8/26, A61K 8/27, A61K 8/28, A61K 8/29, A61Q 1/06, A61Q 1/10, A61Q 1/12, B82Y 30/00, C09C 3/00, C09C 3/08
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13710247

METHOD OF ALTERING THE IMMUNDOMINANCE HIERARCHY OF HIV GAG BY DNA VACCINE EXPRESSING CONSERVED REGIONS

IPC classification:
C07K 14/16
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
University of Washington CoMotion
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13757943

SIZE-BASED ANALYSIS OF FETAL DNA FRACTION IN MATERNAL PLASMA

IPC classification:
C12Q 1/68, G06F 19/18, G06F 19/20
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13760635

METHODS FOR ANALYZING MASSIVELY PARALLEL SEQUENCING DATA FOR NONINVASIVE PRENATAL DIAGNOSIS

IPC classification:
C12Q 1/68, G06F 19/20
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13715055

SYNTHETIC COMPOUNDS FOR VEGETATIVE ABA RESPONSES

IPC classification:
A01N 43/42, A01P 15/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13767407

ANTI-LAMP5 ANTIBODY AND UTILIZATION THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 19/00, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13717134

GENE EXPRESSION PANEL FOR BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68
Applicant:
Oregon Health & Science University
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13775129

PROCESS FOR PREPARATION OF BENZYLBENZENE SODIUM-DEPENDENT GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS

IPC classification:
A61K 31/7034, A61P 3/10, C07C 39/15, C07C 41/16, C07C 43/225, C07H 7/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP13776184

BIS-POLYMER LIPID-PEPTIDE CONJUGATES AND NANOPARTICLES THEREOF

IPC classification:
A61K 38/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13782257

ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES

IPC classification:
A01K 67/027, A61K 39/395, A61P 29/00, A61P 37/08, C07K 16/28, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Chiba University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13787593

METHOD FOR PREDICTING PROGNOSIS OF RENAL CELL CARCINOMA

IPC classification:
C12N 15/09, C12Q 1/68
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13787178

ANTI-CXADR ANTIBODY

IPC classification:
A61K 39/395, A61K 49/00, A61P 35/00, C07K 16/30, C07K 16/32, C12N 15/02, C12P 21/08, G01N 33/574
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13787381

ANTIBODIES SPECIFIC FOR CLL-1

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13729224

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

IPC classification:
A61K 38/18, A61P 25/00, A61P 25/22, A61P 25/24, A61P 25/28
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13797956

SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR REGULATING EXPRESSION OF GENE HAVING DELIVERING FUNCTION

IPC classification:
A61K 47/48, A61K 48/00, A61P 43/00, C12N 15/09, C12N 15/113
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13730049

ANTI -TRANSGLUTAMINASE 2 ANTIBODIES

IPC classification:
C07K 16/40
Applicant:
Medical Research Council Technology
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11820746

PYRIDYL-AMINE FUSED AZADECALIN MODULATORS

IPC classification:
A61K 31/4162, A61P 25/00, C07D 471/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733322

TREATMENT FOR BONE DISEASES

IPC classification:
A61K 39/395, C07K 16/22
Applicant:
UCB Pharma S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP13813919

WHEAT WITH INCREASED GRAIN-BEARING NUMBER AND METHOD FOR PRODUCING SAME, AND CHEMICAL FOR INCREASING GRAIN-BEARING NUMBER OF WHEAT

IPC classification:
A01H 1/00, A01H 5/00, A01H 5/10, C12N 15/09, C12N 15/113
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13825402

MONOCLONAL ANTIBODY AGAINST HUMAN MIDKINE

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C07K 16/46, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Nagoya University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13828363

PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF

IPC classification:
C12N 5/077, C12N 5/10, C12N 15/09, C12N 15/113, C12Q 1/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13829120

ATTENUATED LIVE VACCINE FOR CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS AND ERVE VIRUS

IPC classification:
A61K 39/12, C12N 7/00, C12N 7/04
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
Colorado Seminary University of Denver
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12747134

DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13834977

METHOD FOR MAINTAINING ORGAN OR TISSUE FOR TRANSPLANTATION USE FOR LONG PERIOD

IPC classification:
A01N 1/02, A61L 27/00
Applicant:
Organ Technologies Inc.
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13843218

METHODS AND APPARATUSES FOR INCREASING MUCOCILIARY CLEARANCE

IPC classification:
A61B 1/00, A61B 5/00, A61B 7/00, A61M 29/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13779699

PROTEOLYTIC INACTIVATION OF SELECT PROTEINS IN BACTERIAL EXTRACTS FOR IMPROVED EXPRESSION

IPC classification:
C07K 14/47, C12N 9/50
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11763562

GENERATION OF ANTIBODIES TO AN EPITOPE OF INTEREST

IPC classification:
A61K 39/00, C07K 16/22, C07K 16/24, C07K 16/44, C40B 10/00, C40B 30/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13854825

SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES

IPC classification:
A61K 35/34
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13855096

GEMCITABINE PRODRUGS AND USES THEREOF

IPC classification:
A61K 31/70, C07H 19/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13801947

HETERODIMERIC IMMUNOGLOBULINS

IPC classification:
A61K 39/395, A61P 19/08, C07K 16/18, C07K 16/22, C07K 16/28, C07K 16/32, C07K 16/46, C07K 19/00
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13856207

NUCLEIC ACIDS USEFUL FOR INTEGRATING INTO AND GENE EXPRESSION IN HYPERTHERMOPHILIC ACIDOPHILIC ARCHAEA

IPC classification:
C12N 15/74
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13850907

COMPLEXES OF PHOSPHINE LIGANDS COMPRISING A CARBA-CLOSO-DODECABORATE SUBSTITUENT

IPC classification:
C07B 61/00, C07F 5/02
Applicant:
The Regents of the University of California - Office of Technology Transfer
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13858466

RNA INTERFERENCE AGENT, METHOD FOR PRODUCING SAME, AND USE THEREOF

IPC classification:
C12N 15/113, C12Q 1/02
Applicant:
Gifu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13857993

ANTICONVULSANT ACTIVITY OF STEROIDS

IPC classification:
A61K 31/56, A61K 47/40, A61P 25/28
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13863107

PERSONALIZED BIOMARKERS FOR CANCER

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13863207

PORPHYRIN MODIFIED TELODENDRIMERS

IPC classification:
A61B 5/00, A61K 31/74, C07D 487/22
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13864639

COMPOSITION HAVING TISSUE REPAIRING ACTIVITY AND UTILIZATION THEREOF

IPC classification:
A61K 31/737, A61K 38/00, A61K 45/00, A61K 45/06, A61P 1/16, A61P 3/10, A61P 9/00, A61P 9/10, A61P 11/00, A61P 17/02, A61P 19/02, A61P 21/00, A61P 25/00, A61P 25/16, A61P 25/28, A61P 27/04, A61P 29/00, A61P 37/02, A61P 37/06, A61P 43/00, C12N 15/09
Applicant:
The University of Tokushima
Applicant:
Nagoya University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13867433

EICOSAPENTAENOIC ACID (EPA) FORMULATIONS

IPC classification:
A61K 31/202, A61K 36/05, A61P 9/00, A61P 25/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13866203

ANTIBODIES THAT BIND MEMBRANE-BOUND IL1RAP

IPC classification:
C07K 16/28
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11801934

NOVEL MODULATORS AND METHODS OF USE

IPC classification:
A61K 39/395, A61K 49/00, C07K 16/22, C07K 16/30, C07K 16/40, G01N 33/574
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
John William Graham Jappy, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP11757079

DETERMINING SUSCEPTIBILITY TO A SUDDEN CARDIAC EVENT

IPC classification:
G01N 33/48, G06F 19/22
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14743597

MICROORGANISM FOR PRODUCTION OF CHEMICALS DERIVED FROM ACETYL-COA

IPC classification:
C12N 1/21, C12P 13/14, C12P 19/32
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14743436

MICROORGANISM HAVING CARBON DIOXIDE FIXATION CYCLE INTRODUCED THEREINTO

IPC classification:
C12N 1/21, C12N 15/09, C12P 1/00
Applicant:
Mitsui Chemicals Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15170550

SINGLE NUCLEOTIDE POLYMORPHISM IN IGF2 FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14705881

METHODS OF SELECTING COMBINATION THERAPY FOR COLORECTAL CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14705880

DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING RECEPTOR TYROSINE KINASE PROFILING

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14706699

DRUG SELECTION FOR NON-SMALL CELL LUNG CANCER THERAPY

IPC classification:
C12Q 1/68
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14748891

ANTIBODIES TO HUMAN NRG1 PROTEIN

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12N 5/10, C12N 15/09, C12P 21/08
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15163893

COMBINATIONS OF POLYMORPHISMS FOR DETERMINING ALLELE-SPECIFIC EXPRESSION OF IGF2

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14757745

ANTIBODY AGAINST INSOLUBLE FIBRIN

IPC classification:
C07K 16/36, C12N 15/02, G01N 33/53
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14723908

MODIFIED PYR/PYL RECEPTORS ACTIVATED BY ORTHOGONAL LIGANDS

IPC classification:
A01N 25/00, C12N 15/82
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14764952

TISSUE AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS AND METASTASIS-PREDICTIVE POTENTIAL IN COLORECTAL CANCER

IPC classification:
C12P 19/34, C12Q 1/68, C40B 40/06
Applicant:
Baylor Research Institute
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15183030

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITING IL-17 ACTIVITY

IPC classification:
A61K 39/395, A61K 47/48, A61P 37/00
Applicant:
UCB Biopharma SPRL
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14763923

PEPTIDES HAVING REDUCED TOXICITY THAT STIMULATE CHOLESTEROL EFFLUX

IPC classification:
A61K 38/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14782359

SOIL METABOLIZABLE CYANAMIDE PESTICIDE COMPOSITIONS

IPC classification:
A01N 59/24
Applicant:
Auburn University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14727670

THE USE OF LAMBDA-GAM PROTEIN IN RIBOSOMAL DISPLAY TECHNOLOGY

IPC classification:
C12N 15/10
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15182430

ANTIBODY SPECIFICITY TRANSFER USING MINIMAL ESSENTIAL BINDING DETERMINANTS

IPC classification:
A61K 39/00, C07K 16/00, C07K 16/12, C12Q 1/70, G01N 33/53
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14787867

FUNCTIONAL MONOCLONAL ANTIBODY AGAINST HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/22, C12N 5/10, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15177122

COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/00
Applicant:
The Scripps Research Institute
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14792250

PROGNOSIS OF RESPONSE TO TREATMENT WITH ANTI-TNF-ALPHA IN PATIENTS WITH RHEUMATOID ARTHRITIS

IPC classification:
C12Q 1/68
Applicant:
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP11838947

BIOMARKERS FOR PREDICTING PROGRESSIVE JOINT DAMAGE

IPC classification:
C12Q 1/68, G01N 33/564, G06F 7/60
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Mark Gibson, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14794936

NUCLEIC ACID OF CODED GPC3 CHIMERIC ANTIGEN RECEPTOR PROTEIN AND T LYMPHOCYTE EXPRESSING GPC3 CHIMERIC ANTIGEN RECEPTOR PROTEIN

IPC classification:
C07H 21/00, C07K 16/28, C12N 5/10, C12N 7/00, C12N 15/09, C12N 15/63
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14794723

ANTIBIOTIC AND ANTI-PARASITIC AGENTS THAT MODULATE CLASS II FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE

IPC classification:
A01N 43/42, A61K 31/535, C07D 215/00, C07D 413/00
Applicant:
Regis University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14805118

METHOD FOR DEBITTERING OLIVES

IPC classification:
A23L 11/30
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14728658

METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF COLORECTAL CANCER PATIENTS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Sri Krishnan, Nestec S.A.
Status:
EXAMINATION IN PROGRESS
EP14733761

A METHOD OF BIOLOGICAL TARGET DETECTION USING A NANOPORE AND A FUSION PROTEIN BINDING AGENT

IPC classification:
C12Q 1/68, G01N 33/487
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11802817

LOW TEMPERATURE CHLORINATION OF CARBOHYDRATES

IPC classification:
C07H 5/02, C07H 13/04, C07H 13/08
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14733677

SINGLE DOMAIN ANTIBODY DISPLAY

IPC classification:
A61K 39/00, C07K 14/005, C07K 16/46, C12N 15/62, G01N 33/50
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14803370

HETEROMULTIMERS WITH REDUCED OR SILENCED EFFECTOR FUNCTION

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/28, C07K 16/46, C12N 15/13
Applicant:
Zymeworks Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
GRANT OF PATENT INTENDED
EP14813532

CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
A61K 9/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14818118

MULTIPLEXED BIOMARKER QUANTITATION BY NANOPORE ANALYSIS OF BIOMARKER-POLYMER COMPLEXES

IPC classification:
C12Q 1/68, G01N 33/00, G01N 33/50, G01N 33/53, G01N 33/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12180292

Method for inhibiting bone resorption

IPC classification:
A61K 39/395, A61P 19/08, C07K 16/18
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP15188222

DIARYLTHIOHYDANTOIN COMPOUNDS USEFUL FOR THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER

IPC classification:
A61K 31/4166, A61P 35/00, C07D 233/86
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14826104

MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE

IPC classification:
A61P 1/00
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14838211

METHODS FOR EVALUATING AND SCREENING S1P1 RECEPTOR AGONISTS

IPC classification:
A61K 31/397, A61K 45/00, A61P 37/06, A61P 43/00, C07K 14/705, G01N 33/15, G01N 33/50
Applicant:
Meiji Seika Pharma Co., Ltd (Meiji Seika Kabushiki-gaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12193684

Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer

IPC classification:
A61K 31/4166, A61K 31/4184, A61P 35/00, C07D 233/72, C07D 233/84, C07D 233/86, C07D 233/88, C07D 235/02, C07D 401/04, C07D 403/04, C07D 403/10
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14839864

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/10, C12N 15/09
Applicant:
National Institute of Advanced Industrial Science and Technology
Applicant:
Gifu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14838934

MOLECULE DETECTION USING BORONIC ACID SUBSTITUTED PROBES

IPC classification:
C12N 9/00, C12P 21/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14845308

METHODS OF TREATMENT USING BIS-POLYMER LIPID-PEPTIDE CONJUGATES AND NANOPARTICLES THEREOF

IPC classification:
A61K 47/42
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14846696

SYSTEMS AND METHODS OF TREATMENT USING INTERVENTION AND TASKING DETERMINATION

IPC classification:
G06Q 50/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP13178047

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

IPC classification:
A61K 31/4166, A61K 31/4178, A61K 31/4439, C07D 233/86, C07D 401/04
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP11763396

REPROGRAMMING CELLS

IPC classification:
C12N 5/074
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
PATENT GRANTED
EP14852607

PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES

IPC classification:
C07C 37/00, C07C 41/01, C07C 309/29
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14852519

NON-NATURAL AMINO ACID tRNA SYNTHETASES FOR PARA-METHYLAZIDO-L-PHENYLALANINE

IPC classification:
C07K 1/00, C07K 14/00, C07K 17/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14852695

DRUG FOR PREVENTION OR TREATMENT OF SPINOCEREBELLAR DEGENERATION

IPC classification:
A61K 31/4535, A61K 31/4545, A61K 31/4709, A61K 31/519, A61K 31/5377, A61K 31/55, A61K 31/553, A61K 38/00, A61K 45/00, A61K 48/00, A61P 25/00, C12N 15/09, C12Q 1/25, C12Q 1/48, C12Q 1/68, G01N 33/15, G01N 33/50
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14789990

SYNTHESIS OF 1-ALKYL-2-AMINO-IMIDAZOL-5-CARBOXYLIC ACID ESTER VIA CALPHA-SUBSTITUTED N-ALKYL-GLYCINE ESTER DERIVATIVES

IPC classification:
C07D 317/12, C07F 9/22
Applicant:
Merck Patent GmbH
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14855465

COMPOUNDS FOR USE IN PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES AND PAIN

IPC classification:
C07D 498/02, C07D 515/02
Applicant:
Academia Sinica
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16150667

SHP-2 GENE MUTATIONS IN MELANOMA

IPC classification:
C07H 21/02, C07H 21/04, C07K 14/435, C12P 19/34, C12Q 1/68, G01N 33/53
Applicant:
The Regents of the University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION REQUESTED
EP14857072

TREATMENT OF METASTATIC PROSTATE CANCER

IPC classification:
A61K 31/165, A61K 31/40, A61K 38/00, A61K 38/17, C07K 14/54
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14795928

ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 47/48
Applicant:
Pfizer Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16157900

GANODERMA LUCIDUM STRAIN SUITABLE FOR LARGE-SCALE LIQUID FERMENTATION CULTURE, METHOD OF MUTATION BREEDING THE SAME, AND APPLICATION THEREOF

IPC classification:
A01H 4/00, C12N 1/14, C12R 1/645, C12R 1/885
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14859656

ANTIBODY HAVING BROAD NEUTRALIZING ACTIVITY IN GROUP 1 INFLUENZA A VIRUS

IPC classification:
A61K 39/395, A61P 31/16, C07K 16/10, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Osaka University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14862612

DUPLICATING DNA WITH CONTIGUITY BARCODES FOR GENOME AND EPIGENOME SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP12191154

Lipid encapsulated interfering RNA

IPC classification:
A61K 9/127, C12N 15/11
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12780983

CHLORINATION OF CARBOHYDRATES AND CARBOHYDRATE DERIVATIVES

IPC classification:
C07H 1/00, C07H 13/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11805738

DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS

IPC classification:
G01N 33/574
Applicant:
Nestec S.A.
Agent:
Patrick John Henry Campbell, J A Kemp
Agent:
Christian Rupp, Mitscherlich PartmbB
Status:
APPLICATION WITHDRAWN
EP14863514

OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

IPC classification:
A61K 31/4162, A61K 31/4375, C07D 471/04
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14851833

NOVEL ALKYLATING AGENT FOR ALKYLATING TARGET WITH DRIVER ONCOGENE MUTATION

IPC classification:
A61K 31/403, A61K 47/34, A61K 47/48, A61P 35/00, C07D 403/14, C08L 77/00, C12N 15/09
Applicant:
Kyoto University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14821000

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS G PROTEIN FRAGMENTS

IPC classification:
A61K 39/00, A61K 39/155, C07K 14/05
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14870595

CANCER DETECTION METHOD USING SENSE OF SMELL OF NEMATODE

IPC classification:
G01N 33/00, G01N 33/493
Applicant:
Kyushu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14872472

CONDUCTIVE HYDROGELS FOR AFFINITY SENSING

IPC classification:
G01N 27/327
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14875056

METHOD FOR DIAGNOSIS OF ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, DIAGNOSTIC AGENT, THERAPEUTIC AGENT, AND SCREENING METHOD FOR SAID AGENTS

IPC classification:
A61K 45/00, A61P 25/28, C12Q 1/48, G01N 33/15, G01N 33/50, G01N 33/68
Applicant:
Tokyo Medical and Dental University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15737917

THERAPEUTIC PHARMACEUTICAL COMPOSITION EMPLOYING ANTI-SLC6A6 ANTIBODY

IPC classification:
A61K 39/395, A61K 45/00, A61K 51/00, A61P 1/00, A61P 15/00, A61P 35/00, C07K 16/28, C12N 15/09
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15741076

SELF-ASSEMBLED BETA SOLENOID PROTEIN SCAFFOLDS

IPC classification:
C07K 14/47, C12N 9/14
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14705225

CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES

IPC classification:
A61K 31/506, A61P 3/06, A61P 9/00
Applicant:
Mitsubishi Tanabe Pharma Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16171151

DIARYLHYDANTOIN COMPOUNDS AS ANDROGEN RECEPTOR ANTAGONISTS FOR TREATMENT OF CANCER

IPC classification:
A61K 31/4166, A61K 31/4184, A61P 35/00, C07D 233/72, C07D 233/84, C07D 233/86, C07D 233/88, C07D 235/02, C07D 401/04, C07D 403/04, C07D 403/10
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
Request for examination was made
EP15751793

SELECTIVE PHOTO ACTIVATION OF AMINO ACIDS FOR SINGLE STEP PEPTIDE COUPLING

IPC classification:
C07K 1/04, C07K 1/10
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15708565

VACCINES BASED ON HEPATITIS B CORE ANTIGENS

IPC classification:
A61K 39/02, A61K 39/12, A61K 39/29, A61K 39/385
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15752216

FORMULATIONS FOR SMALL INTESTINAL DELIVERY

IPC classification:
A61K 39/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16183642

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER

IPC classification:
A61K 31/00, A61K 31/4166, A61K 31/437, A61K 31/567, A61K 31/569, A61K 31/573, A61K 38/00, A61K 45/06, A61P 35/00, A61P 35/04
Applicant:
University of Chicago
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16183850

ALLOGRAFTS COMBINED WITH TISSUE DERIVED STEM CELLS FOR BONE HEALING

IPC classification:
A01N 1/02, A61K 35/12, A61K 35/38, A61K 47/02, A61L 27/12, A61L 27/36, A61L 27/38, A61L 27/54, C12N 5/0775
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION PUBLISHED
EP15761367

TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS

IPC classification:
A61K 38/14, C07D 257/08
Applicant:
The Research Foundation for The State University of New York
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15752232

METHOD FOR PREDICTING RESPONSIVENESS TO CANCER TREATMENT USING p300-INHIBITING COMPOUND

IPC classification:
A61P 35/00, C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
National Cancer Center (Japan)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15765883

MICROORGANISMS PRODUCING L-AMINO ACIDS AND PROCESS FOR PRODUCING L-AMINO ACIDS USING THE SAME

IPC classification:
C12N 1/21, C12N 15/70, C12P 13/04
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15764058

MICROORGANISMS HAVING ENHANCED L-AMINO ACIDS PRODUCTIVITY AND PROCESS FOR PRODUCING L-AMINO ACIDS USING THE SAME

IPC classification:
C12N 1/21, C12N 15/70, C12P 13/04
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15769869

APTAMER INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN BY BINDING WITH AUTOTAXIN, AND USE THEREOF

IPC classification:
A61K 31/7088, A61K 45/00, A61K 48/00, A61P 43/00, C12N 15/00, C12N 15/115, C12Q 1/68, G01N 33/53, G01N 33/566
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767725

APTAMER FOR FGF2 AND USE THEREOF

IPC classification:
A61K 31/7088, A61K 31/712, A61P 9/00, A61P 19/02, A61P 29/00, A61P 35/00, A61P 37/06, A61P 37/08, C12N 15/115
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15768790

TRANSESTERIFICATION REACTION BY MEANS OF IRON CATALYST

IPC classification:
B01J 31/22, C07B 61/00, C07C 67/03, C07C 69/612, C07C 69/618, C07C 69/78
Applicant:
Kyushu University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15776244

O-SUCCINYLHOMOSERINE PRODUCING MICROORGANISM AND METHOD FOR PRODUCING O-SUCCINYLHOMOSERINE USING SAME

IPC classification:
C12N 1/21, C12N 15/53, C12N 15/70, C12P 13/06
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15779171

BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF

IPC classification:
A61K 38/00, A61K 39/385, C07K 7/06
Applicant:
The Regents of the University of California - Office of Technology Transfer
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16174632

USE OF IL-15-IL-15 RECEPTOR HETERODIMERS TO TREAT LYMPHOPENIA

IPC classification:
A61K 38/17, A61K 38/20, A61K 45/06, A61K 48/00, A61P 37/04, C07K 14/54, C07K 14/715, A61K 47/50
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION PUBLISHED
EP15783801

APTAMER FOR BONDING TO AUTOTAXIN AND INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN, AND USE FOR SAME

IPC classification:
A61K 31/7105, A61K 45/00, A61K 48/00, A61P 11/00, A61P 43/00, C12N 15/115
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP14747765

TARGET DETECTION WITH NANOPORE

IPC classification:
C12Q 1/68, G01N 33/487
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP16194631

VARIANT ACTIVIN RECEPTOR POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/17, C07K 14/71, C12N 5/10, C12N 15/12, C12N 15/861
Applicant:
Amgen Inc
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
APPLICATION PUBLISHED
EP15792849

SCAFFOLD DATA STORAGE AND TARGET DETECTION IN A SAMPLE USING A NANOPORE

IPC classification:
C12Q 1/68, G01N 33/487, G01N 33/53
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15793383

COMPOSITIONS AND METHODS FOR SINGLE-MOLECULE CONSTRUCTION OF DNA

IPC classification:
C12N 15/10
Applicant:
The Regents of the University of California
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15796107

CENTROMERE/KINETOCHORE PROTEIN GENES FOR CANCER DIAGNOSIS, PROGNOSIS AND TREATMENT SELECTION

IPC classification:
C12Q 1/68, G01N 33/53, G01N 33/574
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15727042

SEQUENCING PROCESS

IPC classification:
C12Q 1/68
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15727838

COMPOSITIONS AND METHODS OF DELIVERING TREATMENTS FOR LATENT VIRAL INFECTIONS

IPC classification:
A61K 31/7088, A61P 31/22, C12N 15/113
Applicant:
Stanford Office of Technology Licensing
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15729007

COMPOSITIONS AND METHODS TO TREAT LATENT VIRAL INFECTIONS

IPC classification:
A61K 31/7088, A61P 31/22, C12N 15/113
Applicant:
Stanford Office of Technology Licensing
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15729008

COMPOSITIONS AND METHODS OF DELIVERING TREATMENTS FOR LATENT VIRAL INFECTIONS

IPC classification:
A61K 31/7088, A61P 31/22, C12N 15/113
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15803039

ARTIFICIAL CATALYST SYSTEM CAPABLE OF SUBSTITUTING FOR IN VIVO ACYLATION FUNCTION

IPC classification:
A61K 31/16, A61K 31/4409, A61K 38/00, A61P 35/00, A61P 43/00, C07K 7/00, C12N 15/09, A61K 47/50
Applicant:
University of Tokyo
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15807343

STABLE AQUEOUS ADALIMUMAB PREPARATION

IPC classification:
A61K 9/08, A61K 39/395, A61K 47/02, A61K 47/22, A61P 1/04, A61P 17/06, A61P 19/02, A61P 29/00
Applicant:
Meiji Seika Pharma Co., Ltd (Meiji Seika Kabushiki-gaisha)
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15806561

METHOD FOR JUDGING PROTEIN INTERACTION

IPC classification:
C12N 15/09, C12Q 1/02
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15818940

RECOMBINANT MICROORGANISM PRODUCING QUINOLINIC ACID AND METHOD FOR PRODUCING QUINOLINIC ACID USING SAME

IPC classification:
C12N 1/21, C12N 15/09, C12P 17/10
Applicant:
Cj Cheiljedang Corporation
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15757005

THERAPY SELECTION FOR PSORIASIS AND PSORIATIC ARTHRITIS

IPC classification:
C12Q 1/68
Applicant:
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
Applicant:
Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767345

PROCESS FOR PREPARING SYNTHETIC INTERMEDIATES FOR PREPARING TETRAHYDROQUINOLINE DERIVATIVES

IPC classification:
C07D 215/42, C07D 401/12
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED
EP15767349

PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS

IPC classification:
A61K 31/513, A61P 9/00
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature